ATE549921T1 - Radioaktiv markierte glycintransporter-hemmer - Google Patents

Radioaktiv markierte glycintransporter-hemmer

Info

Publication number
ATE549921T1
ATE549921T1 AT06815187T AT06815187T ATE549921T1 AT E549921 T1 ATE549921 T1 AT E549921T1 AT 06815187 T AT06815187 T AT 06815187T AT 06815187 T AT06815187 T AT 06815187T AT E549921 T1 ATE549921 T1 AT E549921T1
Authority
AT
Austria
Prior art keywords
transporter inhibitors
glycine transporter
radioactive labeled
labeled glycine
radioactive
Prior art date
Application number
AT06815187T
Other languages
English (en)
Inventor
H Donald Burns
Terence Hamill
Craig Lindsley
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE549921T1 publication Critical patent/ATE549921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06815187T 2005-09-29 2006-09-25 Radioaktiv markierte glycintransporter-hemmer ATE549921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72178205P 2005-09-29 2005-09-29
PCT/US2006/036989 WO2007041025A2 (en) 2005-09-29 2006-09-25 Radiolabeled glycine transporter inhibitors

Publications (1)

Publication Number Publication Date
ATE549921T1 true ATE549921T1 (de) 2012-04-15

Family

ID=37906660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06815187T ATE549921T1 (de) 2005-09-29 2006-09-25 Radioaktiv markierte glycintransporter-hemmer

Country Status (5)

Country Link
US (1) US7834031B2 (de)
EP (1) EP1942733B1 (de)
AT (1) ATE549921T1 (de)
ES (1) ES2382818T3 (de)
WO (1) WO2007041025A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005024838D1 (en) 2004-09-30 2010-12-30 Merck Sharp & Dohme Cyclopropylpiperidinglycin-transporter-inhibitor
RU2512529C2 (ru) 2008-11-04 2014-04-10 Ф.Хоффманн-Ля Рош Аг Меченные радиоактивной меткой ингибиторы переносчика глицина 1
EP2403337A4 (de) * 2009-03-03 2012-08-15 Univ Vanderbilt Alkylsulfonyl-2,3-dihydrospiro[inden-1,4'-piperidin]-analoge als glyt1-hemmer, verfahren zu ihrer herstellung sowie ihre verwendung zur behandlung psychiatrischer erkrankungen
BRPI1006398A2 (pt) * 2009-03-19 2019-09-24 Koninklijke Philips Electronics N.V. método e sistema
JP5618047B2 (ja) * 2010-01-29 2014-11-05 国立大学法人千葉大学 ポジトロン断層撮影法およびポジトロン放出化合物
WO2011153359A1 (en) * 2010-06-04 2011-12-08 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
EP2718287A1 (de) 2011-06-07 2014-04-16 F.Hoffmann-La Roche Ag [1,3]oxazine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931270A (en) 1988-07-07 1990-06-05 Nelson Research & Development Method for detecting dopaminergic diseases using fluorine-18 radiolabelled D2 dopamine receptor ligands
AU765603C (en) 1998-04-14 2004-08-05 General Hospital Corporation, The Methods for treating neuropsychiatric disorders
ATE439838T1 (de) * 1998-09-29 2009-09-15 Merck & Co Inc Radiomarkierte neurokinin-1 rezeptor antagonisten
US6303637B1 (en) * 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors
US6458935B1 (en) * 1999-06-23 2002-10-01 Merck & Co., Inc. Radiolabeled farnesyl-protein transferase inhibitors
JP4554202B2 (ja) * 2001-07-24 2010-09-29 メルク・シャープ・エンド・ドーム・コーポレイション 放射性標識神経ペプチドyy5受容体拮抗薬
ATE487479T1 (de) * 2002-09-24 2010-11-15 Merck Sharp & Dohme Radioaktiv markierte neurokinin-1-rezeptor- antagonisten
CA2544981A1 (en) * 2003-11-12 2005-05-26 Merck & Co., Inc. 4-phenyl piperidine sulfonyl glycine transporter inhibitors
EP1729772B8 (de) 2004-03-24 2017-04-19 Merck Sharp & Dohme Corp. Heteroaryl-piperidin-glycin-transporterhemmer

Also Published As

Publication number Publication date
EP1942733B1 (de) 2012-03-21
WO2007041025A3 (en) 2007-08-30
US7834031B2 (en) 2010-11-16
US20090269278A1 (en) 2009-10-29
ES2382818T3 (es) 2012-06-13
EP1942733A4 (de) 2010-11-10
EP1942733A2 (de) 2008-07-16
WO2007041025A2 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
CY2019039I2 (el) Συνθεσεις προκαρυωτικης αμμωνiακης λυασης φαινυλαλανινης και μεθοδοι χρησιμοποιησης αυτων των συνθεσεων
CY1123240T1 (el) Αντισωμα αντι fgf23 και μια φαρμακευτικη συνθεση που το περιλαμβανει
CY1116261T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
CL2007003622A1 (es) Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
NL1031539C2 (nl) Bicyclische [3.1.0] heteroarylamiden als type 1 glycinetransportremmers.
SV2011003834A (es) Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5
CY1114926T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
DE502006005854D1 (de) Scheinwerfer für film- und videoaufnahmen
BR112012011332A2 (pt) agentes direcionados para gadd45beta
EP2311946A4 (de) Antikörper gegen system-asc-aminosäuretransporter 2 (asct2)
CY1118710T1 (el) Συνθεσεις για την θεραπεια της πολλαπλης σκληρυνσης
CY1113309T1 (el) Συνθεσεις και μεθοδοι χρησιμοποιωντας αντι-cs1 αντισωματα για να θεραπευεται πολλαπλο μυελωμα
BRPI0819092A2 (pt) Evolução direcionada usando proteínas que compreendem aminoácidos não naturais.
EP2322562A4 (de) Monoklonaler antikörper und immunassay damit
MA29099B1 (fr) Inhibiteurs de transport de la glycine
IL202598A0 (en) High sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest
CY1115437T1 (el) Υδροξυμεθυλοκυκλοεξυλαμινες
ATE404225T1 (de) Radiofluorierte peptide
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
EP1942733A4 (de) Radioaktiv markierte glycintransporter-hemmer
EP1835927A4 (de) Modifizierte betathymosinpeptide
EP2294197A4 (de) Hhip1-proteinvariante sowie verfahren und verwendungen dafür
EP1942893A4 (de) Piperidin-glycin-transporter-hemmer
CY1116283T1 (el) Δοσολογια μοναδας apadenoson